Review on Different Vesicular Drug Delivery Systems (VDDSs) and Their Applications

被引：24

作者：

Alenzi, Asma M. ^{[1
]}

Albalawi, Sana A. ^{[1
]}

Alghamdi, Shatha G. ^{[1
]}

Albalawi, Rawan F. ^{[1
]}

Albalawi, Hadeel S. ^{[1
]}

Qushawy, Mona ^{[2
,3
]}

机构：

[1] Univ Tabuk, Fac Pharm, Pharm Program D, Tabuk, Saudi Arabia

[2] Univ Tabuk, Fac Pharm, Dept Pharmaceut, Tabuk 71491, Saudi Arabia

[3] Sinai Univ, Fac Pharm, Dept Pharmaceut, Alarish 45511, N Sinai, Egypt

来源：

RECENT PATENTS ON NANOTECHNOLOGY | 2023年 / 17卷 / 01期

关键词：

Drug delivery; niosomes; liposomes; bioavailability; drug targeting; colloidal dispersion; TRANSDERMAL DELIVERY; SYNERGISTIC PENETRATION; ORAL IMMUNIZATION; TOPICAL DELIVERY; IN-VITRO; LIPOSOMES; CUBOSOMES; NIOSOMES; CARRIER; PHARMACOSOMES;

D O I：

10.2174/1872210516666220228150624

中图分类号：

TB3 [工程材料学];

学科分类号：

0805 ; 080502 ;

摘要：

Background: Colloidal dispersions, also known as vesicular drug delivery systems (VDDSs), are highly ordered assemblies composed of one or more concentric bilayers formed by the self-assembly of amphiphilic building blocks in the presence of water. Objective: VDDSs are important to target the entrapped drugs at specific sites inside the body, control the drug release, enhance the drug bioavailability, and reduce undesired side effects. Methods: There are different types of VDDSs suitable for the entrapment of both hydrophilic and lipophilic drugs. According to the patent composition, VDDSs are classified into lipid-based and non-lipid-based VDDSs. Results: There are different types of VDDSs which include liposomes, ethosomes, transferosomes, ufasomes, colloidosomes, cubosomes, niosomes, bilosomes, aquasomes, etc. Conclusion: This review article aims to address the different types of VDDSs, their advantages and disadvantages, and their therapeutic applications.

引用

页码：18 / 32

页数：15

共 139 条

[41] Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale [J].

Fernandez-Garcia, Raquel ;

Lalatsa, Aikaterini ;

Statts, Larry ;

Bolas-Fernandez, Francisco ;

Paloma Ballesteros, M. ;

Serrano, Dolores R. .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 573

[42]

Gaballa S.A., 2020, J. Adv. Biomed. Pharm. Sci, V3, P1, DOI [10.21608/jabps.2019.16887.1057, DOI 10.21608/JABPS.2019.16887.1057]

[43] Cubosomes: An overview [J].

Garg, Gopal ;

Saraf, Shailendra ;

Saraf, Swarnlata .

BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (02) :350-353

[44] UFASOMES ARE STABLE PARTICLES SURROUNDED BY UNSATURATED FATTY-ACID MEMBRANES [J].

GEBICKI, JM ;

HICKS, M .

NATURE, 1973, 243 (5404) :232-234

[45] PREPARATION AND PROPERTIES OF VESICLES ENCLOSED BY FATTY-ACID MEMBRANES [J].

GEBICKI, JM ;

HICKS, M .

CHEMISTRY AND PHYSICS OF LIPIDS, 1976, 16 (02) :142-160

[46]

Godin Biana, 2005, Current Drug Delivery, V2, P269, DOI 10.2174/1567201054367931

[47] CHEMICAL-STABILITY OF LIPOSOMES - IMPLICATIONS FOR THEIR PHYSICAL STABILITY [J].

GRIT, M ;

CROMMELIN, JA .

CHEMISTRY AND PHYSICS OF LIPIDS, 1993, 64 (1-3) :3-18

[48] Antileishmanial activity and immune modulatory effects of benzoxonium chloride and its entrapped forms in niosome on Leishmania tropica [J].

Hakimi Parizi M. ;

Pardakhty A. ;

sharifi I. ;

Farajzadeh S. ;

Daie Parizi M.H. ;

Sharifi H. ;

Keyhani A.R. ;

Mostafavi M. ;

Bamorovat M. ;

Ghaffari D. .

Journal of Parasitic Diseases, 2019, 43 (3) :406-415

[49] Gene therapy and DNA delivery systems [J].

Ibraheem, D. ;

Elaissari, A. ;

Fessi, H. .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 459 (1-2) :70-83

[50] Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin [J].

Imran, Muhammad ;

Shah, Muhammad Raza ;

Ullah, Farhat ;

Ullah, Shafi ;

Elhissi, Abdelbary M. A. ;

Nawaz, Waqas ;

Ahmad, Farid ;

Sadiq, Abdul ;

Ali, Imdad .

DRUG DELIVERY, 2016, 23 (09) :3653-3664

← 1 2 3 4 5 6 7 8 9 10 →